Skip to main navigation Skip to search Skip to main content

Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis

  • Evgenia Alpert
  • , Armin Akhavan
  • , Arie Gruzman
  • , William J. Hansen
  • , Joshua Lehrer-Graiwer
  • , Steven C. Hall
  • , Eric Johansen
  • , Sean McAllister
  • , Mittul Gulati
  • , Ming Fong Lin
  • , Vishwanath R. Lingappa
  • California Pacific Medical Center
  • PROSETTA CORPORATION
  • University of California at San Francisco
  • University of Nebraska Medical Center

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

The role of human prostatic acid phosphatase (PAcP, P15309|PPAP HUMAN) in prostate cancer was investigated using a new proteomics tool termed signal sequence swapping (replacement of domains from the native cleaved amino terminal signal sequence of secretory/membrane proteins with corresponding regions of functionally distinct signal sequence subtypes). This manipulation preferentially redirects proteins to different pathways of biogenesis at the endoplasmic reticulum (ER), magnifying normally difficult to detect subsets of the protein of interest. For PAcP, this technique reveals three forms identical in amino acid sequence but profoundly different in physiological functions, subcellular location, and biochemical properties. These three forms of PAcP can also occur with the wildtype PAcP signal sequence. Clinical specimens from patients with prostate cancer demonstrate that one form, termed PLPAcP, correlates with early prostate cancer. These findings confirm the analytical power of this method, implicate PLPAcP in prostate cancer pathogenesis, and suggest novel anticancer therapeutic strategies.

Original languageEnglish
Article numberBSR20211646
JournalBioscience Reports
Volume41
Issue number10
Early online date4 Oct 2021
DOIs
StatePublished - Oct 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2021 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).

Funding

This work supported by the NIH (to Ming-Fong Lin and Vishwanath R. Lingappa); the CPMC Research Institute; and the Prosetta Corporation of which Vishwanath R. Lingappa is a founder and Chief Technology Officer.

Funders
CPMC Research Institute
Chief Technology Officer
National Institutes of Health

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis'. Together they form a unique fingerprint.

    Cite this